CBT vs PFE · P/E 16, rev $3.71B vs P/E 20, rev $15.03B
Cabot Corporation (CBT) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Cabot Corporation (CBT) is a specialty chemicals company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported CBT revenue for 2025-09-30 was $3.71B. Net income was $376.0M. Revenue was down 7.0% from 2024-09-30 to 2025-09-30. CBT currently screens at market cap $4.29B and trailing P/E 15.7.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
CBT currently screens at market cap $4.29B and trailing P/E 15.7. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the CBT and PFE stock pages for the full models.
Not investment advice.